Area of research
Oncology · Hematology
Research interest
Research interests include CAR-T cell therapy research, Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment, and Epigenetics and DNA Methylation.
CAR-T cell manufacturing failures and out-of-specification products in the real-world setting: A survey from the EBMT cellular therapy and immunobiology working party
DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcripts
Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party
Potential to Improve Therapy of Chronic Myeloid Leukemia (CML), Especially for Patients with Older Age: Incidence, Mortality, and Survival Rates of Patients with CML in Switzerland from 1995 to 2017
Trends of incidence and survival of patients with chronic myelomonocytic leukemia between 1999 and 2014: A comparison between Swiss and American population-based cancer registries
Azacitidine is effective for targeting leukemia-initiating cells in juvenile myelomonocytic leukemia
PF442 TREATMENT WITH 5‐AZACYTIDINE RESULTS IN EXPRESSION OF LONG TERMINAL REPEAT (LTR) ELEMENTS IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF PATIENTS WITH MDS AND AML: FIRST PILOT STUDY
Reactivation of endogenous retroviral elements via treatment with DNMT- and HDAC-inhibitors
DNMT and HDAC inhibitors induce cryptic transcription start sites encoded in long terminal repeats
Azanucleoside DNA Methyltransferase Inhibitor Drugs: Update on Clinical Applications in Myelodysplastic Syndromes and Acute Myeloid Leukemia
Epigenetic Drug Treatment Globally Induces Cryptic Transcription Start Sites Encoded in Long Terminal Repeats
Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia